Krzysztof Kuziak

Krzysztof Kuziak

Auto-generated profile, based on publicly available information

Krzysztof Kuziak

R&D Analytical Chemistry Department, Pharmaceutical Research Institute, 8 Rydygiera Street, 01-793 Warsaw, Poland

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2013 in Molecules
Verified
Journal Article
Open access
PDF file
MŁMarta Łaszcz
Marta Łaszcz
MKMarek Kubiszewski
Marek Kubiszewski
ŁJŁukasz Jedynak
Łukasz Jedynak
MKMonika Kaczmarska
Monika Kaczmarska
ŁKŁukasz Kaczmarek
Łukasz Kaczmarek
MMMaura Malinska
Maura Malinska
In this article the crystal structures of the starting material TZ-5 and the key intermediate TZ-6 of temozolomide (TZ-7), an anticancer therapeutic agent, are presented, together with their spectroscopic and thermal characteristics. Both compounds crystallize in the triclinic P-1 space group. X-ray crystallography studies proved that the compound TZ-6 exists as a monohydrate. A complete structural assignment was obtained for the signals in the 1H-, 13C- and 15N-nuclear magnetic resonance spectra and the structures were confirmed by Fourier-Transform infrared and Raman spectroscopy. The article describes the importance of the high purity of TZ-6 during the small-scale plant production of TZ-7 in a desired polymorphic form III with the purity higher than 99.50%, according to an HPLC method.

22 August 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
ESElżbieta U. Stolarczyk
Elżbieta U. Stolarczyk
MŁMarta Łaszcz
Marta Łaszcz
ALAndrzej Leś
Andrzej Leś
MKMarek Kubiszewski
Marek Kubiszewski
KKKrzysztof Kuziak
Krzysztof Kuziak
KSKrzysztof Stolarczyk
Krzysztof Stolarczyk
The aim of our work was the synthesis and physicochemical characterization of a unique conjugate consisting of gold nanoparticles (AuNPs) and a pharmacologically active anticancer substance abiraterone (AB). The direct coupling of AB with gold constitutes an essential feature of the unique AuNPs–AB conjugate that creates a promising platform for applications in nanomedicine. In this work, we present a multidisciplinary, basic study of the obtained AuNPs–AB conjugate. Theoretical modeling based on the density functional theory (DFT) predicted that the Aun clusters would interact with abiraterone preferably at the N-side. A sharp, intense band at 1028 cm−1 was observed in the Raman spectra of the nanoparticles. The shift of this band in comparison to AB itself agrees well with the theoretical model. AB in the nanoparticles was identified by means of electrochemistry and NMR spectroscopy. The sizes of the Au crystallites measured by XRPD were about 9 and 17 nm for the nanoparticles obtained in pH 7.4 and 3.6, respectively. The size of the particles as measured by TEM was 24 and 30 nm for the nanoparticles obtained in pH 7.4 and pH 3.6, respectively. The DLS measurements revealed stable, negatively charged nanoparticles.

1 August 2016 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MŁMarta Łaszcz
Marta Łaszcz
KTKinga Trzcińska
Kinga Trzcińska
AWAnna Witkowska
Anna Witkowska
ACAgnieszka Ciesielska
Agnieszka Ciesielska
KBKatarzyna Badowska-Rosłonek
Katarzyna Badowska-Rosłonek
KKKrzysztof Kuziak
Krzysztof Kuziak